DNA polymorphism sensitive impedimetric detection on gold-nanoislands modified electrodes

Nanocomposite materials are being increasingly used in biosensing applications as they can significantly improve biosensor performance. Here we report the use of a novel impedimetric genosensor based on gold nanoparticles graphite-epoxy nanocomposite (nanoAu-GEC) for the detection of triple base mut...

ver descrição completa

Detalhes bibliográficos
Autores: Bonanni, Alessandra, Pividori, María Isabel|||0000-0002-5266-7873, Valle, Manel del|||0000-0002-1032-8611
Formato: artículo
Fecha de publicación:2015
País:España
Recursos:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:144743
Acesso em linha:https://ddd.uab.cat/record/144743
https://dx.doi.org/urn:doi:10.1016/j.talanta.2015.01.004
Access Level:acceso abierto
Palavra-chave:Gold nanocomposite
DNA polymorphism
Electrochemical impedance spectroscopy
Cyctic fibrosis
Gold nanoparticles amplification
Descrição
Resumo:Nanocomposite materials are being increasingly used in biosensing applications as they can significantly improve biosensor performance. Here we report the use of a novel impedimetric genosensor based on gold nanoparticles graphite-epoxy nanocomposite (nanoAu-GEC) for the detection of triple base mutation deletion in a cystic-fibrosis (CF) related human DNA sequence. The developed platform consists of chemisorbing gold nano-islands surrounded by rigid, non-chemisorbing, and conducting graphite-epoxy composite. The ratio of the gold nanoparticles in the composite was carefully optimized by electrochemical and microscopy studies. Such platform allows the very fast and stable thiol immobilization of DNA probes on the gold islands, thus minimizing the steric and electrostatic repulsion among the DNA probes and improving the detection of DNA polymorphism down to 2.25 fmol by using electrochemical impedance spectroscopy. These findings are very important in order to develop new and renewable platforms to be used in point-of-care devices for the detection of biomolecules.